sb 202190 has been researched along with Antiphospholipid Syndrome in 1 studies
4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole: structure given in first source; inhibits p38 MAP kinase
Antiphospholipid Syndrome: The presence of antibodies directed against phospholipids (ANTIBODIES, ANTIPHOSPHOLIPID). The condition is associated with a variety of diseases, notably systemic lupus erythematosus and other connective tissue diseases, thrombopenia, and arterial or venous thromboses. In pregnancy it can cause abortion. Of the phospholipids, the cardiolipins show markedly elevated levels of anticardiolipin antibodies (ANTIBODIES, ANTICARDIOLIPIN). Present also are high levels of lupus anticoagulant (LUPUS COAGULATION INHIBITOR).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jovanović Krivokuća, M | 1 |
| Abu Rabi, T | 1 |
| Stefanoska, I | 1 |
| Vrzić-Petronijević, S | 1 |
| Petronijević, M | 1 |
| Vićovac, L | 1 |
1 other study available for sb 202190 and Antiphospholipid Syndrome
| Article | Year |
|---|---|
Immunoglobulins from sera of APS patients bind HTR-8/SVneo trophoblast cell line and reduce additional mediators of cell invasion.
Topics: Antiphospholipid Syndrome; Cell Line; Cell Movement; Cell Survival; Enzyme Inhibitors; Female; Human | 2017 |